Lin Elizabeth Yeu

Chief Medical OfficerTarsus Pharmaceuticals, Inc. (TARS) · full profile →Form 4 · filed Mar 19, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$78K
Net Open-Market Flow
-$78K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 19, 2026Sell(S)390$67.00$26K23K
Mar 18, 2026Sell(S)379$68.71$26K24K
Mar 17, 2026Sell(S)375$69.42$26K24K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001842190-26-000007) within minutes of acceptance. Every field above traces to the original document. Verify it directly: